Disclosures for "The Cost Burden of Alzheimer’s Disease on Care Partners")
-
Mrs. Hviid Hahn-Pedersen has stock in Novo Nordisk.
-
Mr. Solís-Tarazona has received personal compensation for serving as an employee of Novo Nordisk A/S. Mr. Solís-Tarazona has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB Pharma Spain.
-
The institution of Prof. Holm-Larsen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Novo Nordisk.